RPG Life Sciences Subsidiary Amalgamation Approved

RPG Life Sciences Ltd's subsidiary, RPG Active Pharma Limited (RPGAP), has approved a Scheme of Amalgamation with its wholly-owned subsidiary, Actis Generics Private Limited. The amalgamation, subject to NCLT and shareholder approvals, aims to streamline corporate structure, consolidate assets and liabilities, and improve operational efficiencies. Actis Generics reported a net worth of ₹34.60 Crore and revenue of ₹45.96 Crore in FY26, while RPGAP had a net worth of ₹34.75 Crore as of March 31, 2026. The merger is expected to create cost savings, enhance the balance sheet, and improve business synergy.